scholarly journals Trastuzumab versus observation for HER2 nonamplified early breast cancer with circulating tumor cells (EORTC 90091-10093, BIG 1-12, Treat CTC): a randomized phase II trial

2018 ◽  
Vol 29 (8) ◽  
pp. 1777-1783 ◽  
Author(s):  
M. Ignatiadis ◽  
S. Litière ◽  
F. Rothe ◽  
S. Riethdorf ◽  
C. Proudhon ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Tumor Cells ◽  
Circulating Tumor Cells ◽  
Early Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Randomized Phase Ii

scholarly journals A Randomized Phase II Trial Investigating the Effect of Platelet Function Inhibition on Circulating Tumor Cells in Patients With Metastatic Breast Cancer

2013 ◽  
Vol 13 (6) ◽  
pp. 409-415 ◽  
Author(s):  
Ryan P. Roop ◽  
Michael J. Naughton ◽  
Catherine Van Poznak ◽  
Jochen G. Schneider ◽  
Philip E. Lammers ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Tumor Cells ◽  
Circulating Tumor Cells ◽  
Phase Ii ◽  
Platelet Function ◽  
Phase Ii Trial ◽  
Metastatic Breast ◽  
Randomized Phase Ii

The Protective Effect of Zoledronic Acid on Bone Loss in Postmenopausal Women with Early Breast Cancer Treated with Sequential Tamoxifen and Letrozole: A Prospective, Randomized, Phase II Trial

Oncology ◽  
2011 ◽  
Vol 81 (5-6) ◽  
pp. 298-305 ◽  
Author(s):  
Tamar Safra ◽  
Rinat Bernstein-Molho ◽  
Julia Greenberg ◽  
Sharon Pelles-Avraham ◽  
Irina Stephansky ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Zoledronic Acid ◽  
Bone Loss ◽  
Protective Effect ◽  
Postmenopausal Women ◽  
Early Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Randomized Phase Ii
Sign in / Sign up

Export Citation Format

Share Document